Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice

Pharmacology, Toxicology and Pharmaceutical Science

• Mangiferin 100%
• 1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine 83%
• Antiapoptotic 66%
• Dopamine Receptor Stimulating Agent 50%
• Antioxidant 33%
• Nerve Degeneration 33%
• Motor Dysfunction 33%
• Protein 16%
• Dopamine 16%
• Neuroprotective Agent 16%
• Experimental Parkinsonism 16%
• Parkinson Disease 16%
• Mouse Model 16%
• Glucoside 16%
• Protective Agent 16%
• Antidiabetic Agent 16%
• C57BL 6 Mouse 16%
• Polyphenol 16%
• Nerve Cell Degeneration 16%

Medicine and Dentistry

• Mangiferin 100%
• Stereotypic Movement Disorder 33%
• Experimental Parkinsonism 16%

Agricultural and Biological Sciences

• Glucoside 50%